Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
Cutler
F J
FJ
Niciu
C
C
Murphy
J A
JA
Soutar
R L
RL
D001803:Blood Transfusion / Q000401:mortality; D004791:Enzyme Inhibitors / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000209:etiology* / Q000517:prevention & control*; D006291:Health Policy; D006801:Humans; D012189:Retrospective Studies; D012307:Risk Factors; D065227:Transfusion Reaction; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D004791:Enzyme Inhibitors; D014740:Vidarabine; C024352:fludarabine